ARRA: H1N1 and Other ARRA Equipment

疫苗研究中心(VRC)致力于将基础科学知识转化为临床疫苗产品。这就需要有能力进行基础研究，构建新的疫苗产品，进行临床前研究，并在人体试验中评估候选疫苗。为了进行人体临床试验，VRC建立了基础设施，利用良好的生产实践生产疫苗产品，并管理与人体试验相关的监管问题。 为了应对开发针对可能爆发大流行的流感毒株的改进流感疫苗的需要，VRC正在进行一项计划，以开发新的疫苗方法。 这项题为“H1N1和其他ARRA设备”的项目涉及设备采购，以支持VRC范围内的通用流感疫苗开发和生产活动。 与这些设备采购相关的科学活动包括基础研究、转化研究和临床研究。

The Vaccine Research Center (VRC) is dedicated to translating basic science knowledge into clinical vaccine products. This requires the ability to carry out basic research, construct new vaccine products, perform preclinical research and evaluate candidate vaccines in human studies. To conduct human clinical trials, the VRC has established the infrastructure to produce vaccine products using good manufacturing practices, and to manage regulatory issues related to human trials. In response to the need to develop improved influenza vaccines protective against influenza strains with the potential for pandemic outbreaks, the VRC has an ongoing program to develop novel vaccine approaches. This project, entitled "H1N1 and Other ARRA Equipment" concerns equipment purchases to support VRC-wide activities for universal influenza vaccine development and production. Scientific activities related to these equipment purchases include basic research, translational research, and clinical research.